Research Analysts Offer Predictions for MNPR Q2 Earnings
Monopar Therapeutics Inc. (NASDAQ:MNPR – Free Report) – Stock analysts at Brookline Capital Management upped their Q2 2025 earnings estimates for shares of Monopar Therapeutics in a note issued to investors on Tuesday, May 13th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings of ($0.55) per share for the […]
